$MC

Moelis & Co (MC): Submission of Matters to a Vote of Security Holders

Moelis & Co (MC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K Moelis & Co false 0001596967 0001596967 2026-06-25 2026-06-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported

Original reporting
Published Jun 26, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$MC
Neutral
medium confidence
Mentioned
$MC
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MCNeutralLow
01

Why it matters

The disclosure finalizes outcomes for (1) election of seven directors, (2) non-binding advisory approval of named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor for the fiscal year ending Dec. 31, 2026.

02

Market read

Confirms governance decisions and reduces uncertainty around board/auditor approval, but provides no new financial or strategic information.

03

What to watch

Traders may instead focus on any concurrent 8-K items (not present here) such as executive changes, financing, or litigation—this filing alone is not a fundamental driver.

Relevance 6/10Novelty 2/10Timing: after-hours/filing update following the June 25 annual meeting

Background

Moelis & Co (MC) submitted an SEC Form 8-K under Item 5.07 to report final results of votes at its 2026 Annual Meeting of Stockholders held June 25, 2026.

Company-level read

Ticker impact

$MCNeutralMedium confidence
Context

Moelis & Co filed an 8-K reporting final vote results from its June 25, 2026 annual meeting, including director elections and auditor ratification.

Expected impact

Low likelihood of a sustained price move solely from these vote tallies; any reaction would be limited to governance sentiment.

Evidence & confidence

An 8-K Item 5.07 is procedural (final tabulation) and does not introduce new financial guidance, transactions, or enforcement outcomes.

Market effects

Minimal; governance vote outcomes are company-specific and do not signal sector-wide regulatory or earnings changes.

Minimal; no cross-border transaction or macro linkage is disclosed.

Minimal; the disclosure is limited to corporate governance mechanics.

Counterpoint

If there were unusually close votes (e.g., director or comp opposition), it could hint at shareholder dissatisfaction; however, the filing provides no narrative or thresholds to interpret that as a catalyst.

Key entities

  • Moelis & Co

    Subject of the 8-K; reported final shareholder vote tabulations for board, advisory comp, and auditor ratification.

  • Deloitte & Touche LLP

    Independent registered public accounting firm ratified by stockholders for 2026.

Related articles

$MCMed

Moelis & Co (MC): Results of Operations and Financial Condition

Moelis & Co (MC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share • Record second quarter revenues of $409.4 million, up 12% from the prior year period • Recor

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.